References

2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association

10.1161/str.0000000000000436 · 2023 · External reference

Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage

10.1007/s12028-023-01713-5 · 2023 · External reference

Contemporary management of aneurysmal subarachnoid haemorrhage: an update for the intensivist

10.1007/s00134-024-07387-7 · 2024 · External reference

Perioperative management of aneurysmal subarachnoid hemorrhage

10.1097/aln.0000000000003558 · 2020 · External reference

Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU

10.1097/ccm.0000000000003299 · 2018 · External reference

The impact of sedative choice in the management of aneurysmal subarachnoid hemorrhage: a scoping review

10.1007/s12028-024-02111-1 · 2025 · External reference

Sedation protocols in non-traumatic SAH (SPRINT-SAH): a cross-sectional survey among German-speaking neurointensivists

10.3389/fneur.2023.1058804 · 2023 · External reference

Risk factors and outcomes after interruption of sedation in subarachnoid hemorrhage (ROUTINE-SAH): a retrospective cohort study

10.3389/fneur.2024.1363107 · 2024 · External reference

Role of dexmedetomidine in aneurysmal subarachnoid hemorrhage: a comprehensive scoping review

10.1097/ana.0000000000000728 · 2022 · External reference

The nimodipine-sparing effect of perioperative dexmedetomidine infusion during aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial

10.3389/fphar.2019.00858 · 2019 · External reference

Cerebral autoregulation after aneurysmal subarachnoid haemorrhage: a preliminary study comparing dexmedetomidine to propofol and/or midazolam

10.1111/aas.13663 · 2020 · External reference

A retrospective observational pilot study on the effects of dexmedetomidine on neurological outcomes after aneurysmal subarachnoid hemorrhage

10.1016/j.jclinane.2020.110106 · 2021 · External reference

Association between dexmedetomidine use and neurological outcomes in aneurysmal subarachnoid hemorrhage patients: a retrospective observational study

10.1016/j.jcrc.2017.10.034 · 2018 · External reference

A competing risk model analysis of dexmedetomidine of in-hospital mortality in subarachnoid hemorrhage patients

10.1038/s41598-024-81025-6 · 2024 · External reference

Dexmedetomidine reduces in-hospital mortality in aneurysmal subarachnoid hemorrhage patients by modulating three key genes and inflammatory pathways: insights from clinical and bioinformatics analyses

10.3389/fneur.2025.1554809 · 2025 · External reference

Dexmedetomidine is associated with reduced in-hospital mortality risk of patients with subarachnoid hemorrhage undergoing surgery

10.1016/j.wneu.2024.11.122 · 2025 · External reference

Comparison of the effect of low-dose and standard-dose dexmedetomidine infusion on neurological outcomes in patients with aneurysmal subarachnoid hemorrhage undergoing aneurysmal neck clipping: a randomized controlled trial

10.1097/ana.0000000000001069 · 2025 · External reference

The strengthening the reporting of observational studies in epidemiology statement: guidelines for reporting observational studies

10.1016/s0140-6736(07)61602-x · 2007 · External reference

Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group

10.1161/strokeaha.110.589275 · 2010 · External reference

Moving towards best practice when using inverse probability of treatment weighting using the propensity score to estimate causal treatment effects in observational studies

10.1002/sim.6607 · 2015 · External reference

Balancing covariates via propensity score weighting

10.1080/01621459.2016.1260466 · 2018 · External reference

Sensitivity analysis in observational research: introducing the E-value

10.7326/m16-2607 · 2017 · External reference

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

10.1136/bmj.298.6674.636 · 1989 · External reference

Nimodipine in aneurysmal subarachnoid hemorrhage: are old data enough to justify its current treatment regimen?

10.1007/s12028-024-02182-0 · 2025 · External reference

Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study

10.1136/bmj.j5745 · 2018 · External reference